| Financial Year |
March 31 2023 |
| Monetary Funds |
407,207,505.93 |
| Held-for-trading Financial Assets |
538,403,009.67 |
| Notes Receivable |
12,350,000.00 |
| Accounts Receivable |
197,594,416.62 |
| Advances to Suppliers |
16,333,881.88 |
| Other Receivables |
3,269,736.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
227,188,530.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,891,424.19 |
| Total Current Assets |
1,404,238,504.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
359,555,692.89 |
| Under-construction Projects |
90,273,892.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
170,951,254.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,237,660.30 |
| Deferred Income Tax Assets |
1,199,911.81 |
| Other Non-Current Assets |
9,479,757.78 |
| Sub-Total of Non-Current Assets |
645,667,547.31 |
| Total Assets |
2,049,906,052.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
1,387,015.49 |
| Notes Payable |
27,588,887.62 |
| Accounts Payable |
92,388,564.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,064,076.32 |
| Taxes Payable |
11,003,951.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,463,068.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,825,874.52 |
| Other Current Liabilities |
2,907,279.68 |
| Sub-Total of Current Liabilities |
177,305,334.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,423,937.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,483,448.08 |
| Total Liabilities |
197,788,782.25 |
| Paid-In Capital(Or Share Stock) |
101,123,600.00 |
| Capital Surplus |
951,836,267.21 |
| Surplus Reserve |
63,758,936.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
737,505,378.93 |
| Minority Stockholder's Interest |
-2,106,912.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,854,224,182.80 |
| Owner's Equity（Stockholder's Equity） |
1,852,117,270.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,049,906,052.28 |
